Explore Health Grants Nationwide

The purpose of this grant is to support research aimed at developing new screening methods and therapeutic interventions for serious conditions identified through newborn screening, particularly for "high priority" genetic conditions that could benefit from early detection and treatment. Eligible applicants include state and local governments, nonprofits, educational institutions, small businesses, and various other organizations, including those serving specific communities. To apply, interested parties should refer to the full opportunity announcement for detailed application instructions.

The purpose of this grant is to utilize NICHD clinical research Network infrastructure to conduct innovative, multisite, investigator-initiated clinical trials and observational studies focused on infants, children, women, pregnant and lactating women, and persons with disabilities. Eligible applicants include state and local governments, educational institutions, for-profit and nonprofit organizations, and various community-based organizations, among others. Applications must be submitted as multi-Project Director/Principal Investigator grant applications in collaboration with a NICHD-supported Network Data Coordinating Center.

The grant aims to support innovative research into the biological and genetic causes of cancer health disparities, encouraging studies that explore mechanistic factors, develop new methodologies, and conduct secondary data analyses. Eligible applicants include a wide range of organizations such as nonprofits, government entities, small businesses, educational institutions, and various tribal organizations. Application details are not specified in the provided text, but interested parties can contact NIH Grants Information for further inquiries.

The purpose of this grant is to support research proposals focused on current topics related to Alzheimer's disease and its related dementias. Eligible applicants include public and private higher education institutions, small businesses, nonprofits, government entities, and various organizations serving specific communities. To apply, interested parties should refer to the full opportunity announcement for detailed application instructions.

The purpose of this grant is to provide funding for the pre-clinical and early stage clinical development of novel drug candidates aimed at preventing Alzheimer's disease, slowing its progression, or treating its symptoms. Eligible applicants include public and private higher education institutions, government entities, nonprofits, and small businesses, among others. To apply, interested parties should refer to the full opportunity announcement for detailed application instructions.

The purpose of this grant is to invite renewal applications for existing NINDS-supported clinical trial cooperative agreement awards (U01) that require additional time and resources to complete their clinical trials. Eligible applicants include public and Indian housing authorities, independent school districts, various federal agencies, faith-based or community-based organizations, and Indian/Native American Tribal Governments, among others; however, non-domestic entities are not eligible. To apply, interested parties should refer to the full opportunity announcement for detailed application instructions and contact NIH Grants Information for further inquiries.

The grant aims to support the discovery and development of new treatments for mental disorders, substance use disorders, and alcohol use disorder, encouraging partnerships between academia and industry. Eligible applicants include independent school districts, public and private higher education institutions, various nonprofit organizations, government entities, and for-profit businesses. Application details are not specified in the provided text; however, interested parties should refer to the full opportunity announcement for more information.

The grant aims to advance the discovery and development of new treatments for mental disorders, substance use disorders, and alcohol use disorder, encouraging partnerships between academia and industry. Eligible applicants include public and private higher education institutions, nonprofits, government entities, and for-profit organizations, among others. Application details are not specified in the provided text, but interested parties should refer to the full opportunity announcement for more information.

The purpose of this grant is to support well-planned clinical trials in cancer prevention and control, addressing gaps in information that can hinder trial design and execution. Eligible applicants include small businesses, various educational institutions, state and local governments, nonprofits, and other organizations, including those serving specific communities. To apply, interested parties should refer to the full opportunity announcement for detailed application instructions.

The purpose of this grant is to support well-planned clinical trials in cancer prevention and control, addressing gaps in information that can hinder trial design and execution. Eligible applicants include various nonprofit organizations, educational institutions, government entities, small businesses, and other specified groups such as Native American tribal organizations and historically black colleges. Application details are not provided in the description; interested parties should refer to the full opportunity announcement for more information.

The grant aims to provide funding for pharmacodynamic, pharmacokinetic, and in vivo efficacy studies of therapeutic agents intended to treat neurological or neuromuscular disorders, as part of the IGNITE initiative to support initial translational efforts. Eligible applicants include public and private educational institutions, small businesses, nonprofits, various government entities, and other organizations such as tribal colleges and historically black colleges. Application details are not specified in the provided text; interested parties should refer to the full opportunity announcement for further instructions.

The grant aims to support the development and validation of animal models and human/animal tissue ex vivo systems that mimic neurological or neuromuscular disorders, enhancing the translational relevance for neurotherapeutics. Eligible applicants include various government entities, nonprofits, educational institutions, for-profit organizations, and other specified groups. To apply, interested parties should refer to the full opportunity announcement for detailed application instructions.